Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

243 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Active, not recruiting

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

NCT05243550

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Arizona Urology Specialists Tucson, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Genesis Research San Diego, California, United States
  • Wichita Urology Group Wichita, Kansas, United States
View all 65 locations
View Trial Details
Active, not recruiting

A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

NCT05661955

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The Second Hospital and Clinical Medical School, Lanzhou University Lanzhou, Gansu, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Active, not recruiting

Pembrolizumab in Muscle-invasive Bladder Cancer

NCT05406713

Conditions
Carcinoma, Carcinoma, Transitional Cell, Localized Cancer, +5 more
Locations
  • City of Hope Duarte, California, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, not recruiting

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT02845323

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • UCLA Institute of Urologic Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors

NCT03252938

Conditions
Abdominal Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +12 more
Locations
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • Kliniken der Stadt Köln gGmbH, Studienzentrum der Lungenklinik, Krankenhaus Merheim Cologne, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Agaplesion Markus Krankenhaus Frankfurter Diakonie Kliniken gGmbH Frankfurt, Germany
View Trial Details

Related conditions